Costly new breast cancer therapies augment the significant burden this disease places on healthcare resources, but in context they may still provide value to society.
Jeffrey M. Allen, PharmD, BCOP
Advertisement
Articles by Jeffrey M. Allen, PharmD, BCOP
Advertisement
Latest Updated Articles
- Economic/Societal Burden of Metastatic Breast Cancer: A US Perspective
Published: September 21st 2010 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
3
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
4
Aggressive Therapy Recommendations Following the STRONG-HF Trials: Stephen J. Green, MD
5
